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Abstract 
Aquaculture production has seen rapid expansion in the past decade all 
over the world.  Farmed fish would become an important protein 
source among foods than they are today. Enhancing productivity of 
aquaculture often is accompanied by use of chemical compounds such 
as veterinary drugs, feed additives, etc. Chemicals exposed to fish may 
leave the residues in the carcass.  Safety of the products from 
aquaculture for human consumption is of public health concerns. In 
recent years, the presence of veterinary drug residues in farmed fish 
has become an intense issue not only in Japan but also worldwide.  
Foods containing veterinary drugs at unsafe level are not allowed to be 
sold.  The incidence of violation against the Food Sanitation Law is still 
occurred, notwithstanding regulations against the violation have been 
strengthened.  The most recent violation cases in Japan were resulting 
of residue of AOZ (target marker of furazolidone) in imported eel and 
shrimp.  The appropriate risk management of nitrofurans residues 
including its metabolite in farmed fish is urgent task required for fish 
farmers.  Therefore, the main purpose of this research is to obtain the 
essential scientific data to support the chemical risk management on 
AOZ residue in Japanese eel. Due to the higher stability and longer 
residence of AOZ, it has been used as the target analyte for identifying 
the use of furazolidone in animals.  The use of nitrofuran in 
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aquaculture has been prohibited in many countries since no safe levels 
for human health can be set.   In order to provide the information on 
the proper management of furazolidone residue in farmed fish, 
experiments were conducted as follows;  
 
First trial; an effective control of furazolidone in animal tissues can be 
achieved by measuring tissue concentrations of bound furazolidone 
metabolites. Analytical methods reported for the detection of 
furazolidone metabolites in animal tissues have been used UV-HPLV, 
LC-MS and LC-MS/MS.  However, there is now an urgent need for rapid, 
high capacity screening methods for tissue bond residues of the 
furazolidone.  ELISA kit, coupled with minor modification of sample 
preparation was verified for use in the monitoring of eel samples for 
furazolidone metabolite (AOZ).  This ELISA is capable of detecting AOZ 
at 1.0 µg/kg in an eel sample with excellent accuracy and precision. 
And the ELISA-determined concentrations were highly correlated with 
the LC-MS/MS-determined values (r = 0.993, n = 8). Although AOZ 
concentrations measured by our ELISA method tended to 
underestimate the values determined by LC-MS/MS, it is concluded 
that the ELISA method is suitable for regulatory purposes and for 
studying the fate of AOZ residues in eel treated with furazolidone.   
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Second trial; to evaluate the clearance of AOZ from farmed fish tissues 
by using ELISA kit, eels weighing 1.4 to 6.5 were immersed to 2 and 
10 mg furazolidone/L for 3 hours with static water, and then 
maintained in running water at flow rate of 1.2 L/min.  Water 
temperature throughout an experiment period was 23.1 ± 1.5 °C.  Fish 
were fed twice a day at a rate of 1% body weight.  Tissue samples 
were taken at various times between 3 h and 160 days.  At each 
sampling time, 10 fish were sacrificed to obtain muscle and liver.  The 
muscle samples were divided into 5 pairs and the samples in each pair 
were pooled to form 5 replications.  All 10 liver samples were pooled to 
form a designated sample.  In eel exposed to 2 mg/L, muscle AOZ 
level peaked at 360.56 ± 46.03 µg/kg at 48 h and liver AOZ peaked at 
1,578.98 µg/kg at 24h.  Half-lives of AOZ in eel muscle and liver were 
25.0 and 21.6 days, respectively.  In eel treated with 10 mg/L, by 
contrast, higher AOZ levels were detected in both tissues but the half-
lives were similarly to those fish treated with 2 mg/L. Tilapia weighing 
of 5.8 to 9.4 g was used in an imitated above experiment except the 
temperature was 28 ± 0.6 °C.  At each sampling time, 7 fish were 
killed.  The muscle was analyzed individually and liver samples from 7 
fish were pooled.  AOZ concentrations after 3h exposed in muscle and 
liver were 335.00 and 606.21 µg/kg, respectively and decreased 
gradually until below the LOD at 42 days.  The half-lives of AOZ in 
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muscle and liver of tilapia are 5.42 and 4.75 days.  Based on the 
results, it was revealed that AOZ were difficult to eliminate from eel 
tissues in comparison with tilapia.     
 
Third trial; the investigations of selected drug-metabolizing enzymes 
and drug transporter gene expression related to elimination of AOZ in 
eel and tilapia exposed to furazolidone were carried out. Gene 
expressions were quantified by using real-time PCR. Among the 
examined parameters, SPGP which is one of the Phase III transporters 
showed the highest expression level in eel liver at 3 day after exposure.  
Expressions of CYP1A and GST were increased with the passage of 
time from 1 day to 3 days after exposure. MDR1 gene expression was 
maintained at higher level until 28 days after exposure.  In tilapia, the 
dramatic increase of GST gene expression was observed at 1 day post 
exposure. Similarly, extreme gene expressions of MDR1 and ABCG2 
were observed at 1 day and 3hous after exposure, respectively. Gene 
expressions of CYP1A and SPGP were also increased at 3 hours after 
exposure.   These results suggest that the most potent drug 
metabolizing enzymes and drug transporters against furazolidone are 
SPGP, GST and MDR1 in eel liver, and are GST, MDR1, ABCG2 and 
CYP1A in tilapia liver, respectively.  
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Forth trial; the supplementation of feed additives that have the effect 
of enhancement of the excretion of drugs is a concept of this study to 
develop the countermeasures against AOZ residue in farmed fish. 
Chinese parsley - a kind of vegetable and herbal medicine, which 
showed evidences to suppress the heavy metals deposition in rat liver, 
decrease the accumulation of toxic Cadmium in Rainbow trout and also 
enhance the excretion of oxytetracycline form Japanese flounder – was 
added to the diet for experimental eel.  Eel were exposed to 
furazolidone as described in second trial in detail.  The fish were fed 
with diet containing 2 g parsley/kg bodyweight and control diet.  AOZ 
residue in muscle and liver tissues were examined at 7 days after 
immersion.   The obviously evidence that parsley supplemented-diet 
improve AOZ excretion from eel tissues was not obtained.  These 
evidences were confirmed by the gene expression of drug metabolizing 
enzyme after feeding of parsley supplemental diet.  
 
In conclusion, ELISA based-kit validated in present study is fit for the 
purpose to monitoring the use of furazolidone in farmed fish. 
Application of ELISA based-kit for AOZ residue monitoring would make 
it possible for fish farmers to self-imposed monitoring. The half-life of 
AOZ in Japanese eel tissues have revealed. On the basis of the half-life 
of AOZ, a withdrawal period can be fixed.  This control method will be 
beneficial for the risk management of unexpected AOZ residues in eel.  
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A proper risk management program for preventing the occurrence of 
AOZ residues in eel products will be established based on data which 
generated from this research.  
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Chapter 1 General introduction 
 
Various food scandals have been occurring since the outbreaks of 
BSE in 1986. It seems that there is an endless stream of food scandals.    
All across the world, consumers are increasingly concerned about the 
safety and wholesomeness of the food.  Especially, food importing 
countries, such as the United States, Japan and member countries of 
the European Union (EU) are all very aware of food safety. In these 
countries, the requirements of setting various standards regarding food 
safety and of introducing hygienic management systems (Reilly and 
Käferstein, 1997), such as HACCP, are becoming more stringent each 
year. It is essential that   quality of aquaculture products exported to 
these areas meet the standards of importing countries. In the past, a 
hygienic management system was often required for seafood 
processing plants; however, such systems are now considered also 
necessary at the production stage of seafood (fishery, aquaculture).  
Besides the biological risk, such as BSE, contamination with Salmonella 
and Vibriosis, consumers require the assurance for the chemical risk, 
such as harmful chemical pollutants, pesticide and antibiotic residues 
as a result of various food scandals. 
Finfish and shellfish are becoming an increasingly important and 
preferred protein source for humans.  The worldwide decline (through 
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overfishing) of natural resources has been increasing the demand for 
the expansion of aquaculture.  The current FAO definition of 
aquaculture is “the farming of aquatic organisms including fish, 
molluscs, crustaceans and aquatic plants” (FAO/NACA/WHO, 1999).  
Aquaculture supplied the world with about 46 million tons of food fish in 
2004. That is counted for 32.4 percent of total fishery production.  The 
production of the world fisheries products in the period from 2000 to 
2005 (FAO, 2007) was summarized in Table 1.1. According to the same 
FAO publication, Asian countries are the main region of aquaculture 
production. 
 
Table 1.1 World fisheries and aquaculture production (FAO, 2007) 
 
Production/year 
 
2000 
 
2001 
 
2002 
 
2003 
 
2004 
 
2005* 
 
Capture 
 
95.6 
 
93.1 
 
93.3 
 
90.5 
 
95.0 
 
93.8 
 
Aquaculture 
 
35.5 
 
37.9 
 
40.4 
 
42.7 
 
45.5 
 
47.8 
 
Total 
 
131.1 
 
131.0 
 
133.7 
 
133.2 
 
140.5 
 
141.6 
Note; 1) Aquaculture excluding plants; 2) Units are in million tons. 
*Preliminary estimates. 
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There are many different production forms of aquaculture over 
the world, ranging from small-scale subsistence fish farming to 
intensive commercial operations (FAO/NACA/WHO, 1999; Reilly and 
Käferstein, 1997).  Although aquaculture has contributed positively to 
economies of many producing countries, it is pointed out that there are 
some negative impacts against public human health and environment.   
Improvement of the productivity in aquaculture often requires use of 
chemical substances that are potent physiologically, pharmacologically 
and toxicologically.  It means that the animals are exposed to 
chemicals that may leave residues in the edible portion at the time of 
slaughter (Fitzpatric, 1990).  A range of chemicals used in aquaculture 
may be categorized as disinfectants, antifoulants and veterinary 
medicines (Costello, et al., 2001).  The term “medicine” is used as 
alternative terms such as chemotherapeutant in other literatures 
(FAO/NACA/WHO, 1999; Johnston and Santillo, 2002).  It includes 
antibiotics, anaesthetics, ectoparasiticides, endoparasiticides and 
vaccines.  They are used to cure external and internal parasites, or 
microbial infections.  As the terms “antibiotics” and “antimicrobial” are 
often used indiscriminately, the definition has been classified by 
Hernandez (2005). Some examples of use of antibiotics in aquaculture 
in Asian countries are shown by Hernandez (2005) and chemicals 
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products used in south-east Asian shrimp farming were reviewed by 
Graslund and Bengtsson (2001).  
In recent years, the residue of veterinary drug in food has 
become an important issue of intense international concern and debate.  
This issue is not restricted within the scientific community. Consumers 
are expressing their sincere demand for supply of residue-free food. As 
in other animal production sectors, when disease occurs, antibiotics are 
used in aquaculture mainly to prevent (prophylactic use) and cure 
(therapeutic use) infectious disease.  Even though chemicals used in 
widespread in the aquaculture industry, and the generic chemicals in 
use are known, accurate statistics on usage are hard to come by.  As 
pointed out in a recent comprehensive review of chemical use in the 
south-east Asian region (Graslund and Bengtsson, 2001), despite the 
important of this industry, documentation of the quality and quantity of 
chemicals used is scarce.  The only information about the quantity of 
antimicrobial agents’ uses in Norway has been released (see Table 1.2) 
(Grave, 2008).   
The use of antimicrobial agents has fallen exponentially as 
vaccination became popular (Grave and Hansen, 2007; 
FAO/NACA/WHO, 1999).  Usage of antimicrobial agents in aquaculture 
has always been under the regulation, wherever national control 
system exists. Examples of a number of national situations are given in 
General Introduction 
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Table 1.3.  Throughout EU and the United States, limited antibiotics are 
permitted to use for food fish species.  On the other hand, elsewhere in 
the world such as Japan, wider ranges of antibiotics are approved.   
 
Regulation on residues of chemicals in various countries 
 
Regulation of chemicals used in aquaculture covering the medication of 
fish is designed to ensure the quality of available medicinal substances 
and their safety and efficacy in use. To protect the consumer from 
chemical risk in food, regulation of drug residues in aquaculture is an 
important task by regulatory agencies throughout the world.  Food and 
Agriculture Organization of the United Nation (FAO), the World Health 
Organization (WHO), the International Office of Epizootics (OIE) and a 
number of national governments have already raised the issue of 
irresponsible use of antibiotics in all production sectors including 
aquaculture, with particular concern of the potential risks to public 
health.    
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Table 1.2 Sale of Chemicals (per kg active in gradient) for the treatment of farmed fish in Norway, 2001-2007 
  
2001 
 
2002 
 
2003 
 
2004 
 
2005 
 
2006 
 
2007 
 
Florfenicol 
Flumequin 
Lincomycin/Spectinomycin(1:2) 
Oxytetracycline 
Oxolinic acid 
 
Total 
 
109 
7 
- 
12 
517 
 
645 
 
205 
5 
- 
11 
998 
 
1219 
 
154 
60 
- 
45 
546 
 
805 
 
111 
4 
- 
5 
1035 
 
1159 
 
202 
28 
- 
8 
977 
 
1215 
 
302 
7 
50 
- 
1119 
 
1478 
 
139 
18 
67 
19 
406 
 
649 
Source; Grave (2008); 
http://www.fni.no/eway.default.aspx?pid=238&trg=Area_5954&MainLeft_5812=5912=5954:0:&Area_5954=58
25:68486::0:5955:1:::0:0.
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Table 1.3 Antibiotics permitted use in aquaculture 
Country Antibiotics 
The United State (FDA 
Approved) 
(FDA, 2005) 
 
 
Canada 
(approved for aquaculture 
use) (FAO, 2003)  
 
 
United Kingdom 
(licensed for use in fish) 
(Hernandez, 2005) 
 
 
 
Norway 
(large range permitted) 
(Hernandez, 2005) 
 
Sulfadimethoxine 
Ormethoprim 
Oxytetracycline 
 
 
Oxytetracycline 
Sulfadiazine/trimethoprim 
Sulfadimethoxine/ormetoprim 
Florfenicol 
 
Oxytetracycline 
Oxolinic acid 
Amoxicillin 
Co-trimazine  
(Trimethoprim+Sulfadiazine) 
 
Benzylpinicillin+dihydrostreptomycin 
Florfenicol 
Flumequine 
Oxolinic acid 
Oxytetracycline 
Co-trimazine 
(Trimethoprim+Sulfadiazine)  
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Table 1.3 Antibiotics permitted use in aquaculture (cont.) 
Country Antibiotics 
European Union 
(market authourized) 
(Treves-Brown, 2000) 
 
 
 
 
 
 
Mexico  
(Hernandez, 2005) 
 
India 
(Hernandez, 2005) 
 
 
Indonesia 
(Hernandez, 2005) 
 
 
 
 
Thailand  
(Tangtrongpiros, 2005) 
 
Chlortetracycline 
Flumequine 
Oxolinic acid 
Oxytetracycline 
Sarafloxacin 
Sulfamerazine 
Tetracycline 
Trimethoprim/sulfonamide 
 
Enrofloxacin 
Oxytetracycline 
 
Oxytetracycline 
Sulfadiazine+Trimethoprim 
Chlortetracycline 
 
Oxytetracycline 
Erythromycin 
Streptomycin 
Neomycin 
Enrofloxacin 
 
Oxytetracycline 
Sulfadimethoxine+Ormetroprim 
Enrofloxacin 
Sulfamethoxazole+Trimethropeim 
Neomycin  
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Table 1.3 Antibiotics permitted use in aquaculture (cont.) 
Country Antibiotics 
Japan 
(Hernandez, 2005) 
 
 
 
 
 
 
 
 
 
 
China 
(Hernandez, 2005) 
 
 
 
 
 
 
 
The Philippines 
(market authorized) (Treves-
Brown, 2000) 
 
 
 
Amoxicillin 
Ampicillin 
Erythromycin 
Oxytetracycline hydrochloride 
Oxolinic acid 
Spiramycin 
Novobiocin 
Flumequine 
Lincomycin hydrochloride 
Florfenicol 
Thiamphenical 
 
Salfonamide 
Nystatim 
Terramycin 
Penicillin 
Streptomycin 
Doxycycline 
Erythromycin 
Oxolinic acid 
 
Oxolinic acid 
Oxytetracycline 
Ormetoprim/Sulphadimethoxine 
Sulphamerazine 
Sulphisoxazole 
Co-trimazine 
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Table 1.3 Antibiotics permitted use in aquaculture (cont.) 
Country Antibiotics 
Taiwan 
(Treves-Brown, 2000) 
Erythromycin 
Chloramphenicol 
Florfenicol 
Oxytetracycline 
Streptomycin 
Oxolinic acid 
 
Many governments around the world have introduced, changed 
or strengthened national regulations on the use of antibiotics in the 
aquaculture sector. The Codex Alimentarius Commission (CAC) was 
established by FAO and WHO to develop food standards, guidelines 
and related texts such as codes of practice under the Joint FAO/WHO 
Food Standard Program.  The main purposes of this program are 
protecting health of the consumers and ensuring fair trade practices in 
the food supply chain and promoting coordination of all food standards 
work undertaken by international governmental and non-governmental 
organization (http://www.codexalimentarius.net/web/index_en.jsp). 
Consumer safety is protected by the setting of; 
  1) Maximum Residue Limits (MRLs), that have been established 
in each countries based on the recommendation from the Codex 
Committee on Residue of Veterinary Drugs in Food (FAO/OIE/WHO, 
2006), for example, Council Regulation EEC/2377/90 (EU), The 
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Australian Pesticide and Veterinary Medicines Authority (APVM), 
Ministry of Health, Labor and Welfare (MHLW) of Japan.   The MRL 
defines the maximum permissible level of veterinary medicine that 
may be present in foodstuffs from animal origin without presenting any 
harm to human health (Alderman, 1999; Treves-Brown, 2000). MRLs 
are calculated from Non-observed effective level (NOEL) of each 
chemical and the average consumption of each food. 
2) Withdrawal periods; Aquaculture producers are forbad to 
harvest and slaughter an animal without passing the provided time 
from final administration of each drug.  This aspect of regulation is 
concerned with prevention of drug residues.  A withdrawal period is 
determined by the scientific data of pharmacokinetics, i.e. elimination 
time of a drug and its half-life in animal body. The government 
authorities concerned are responsible for the establishment of a 
withdrawal period of each medicine.  Different countries apply different 
withdrawal periods because of the difference of MRL values (Treves-
Brown, 2000). 
In most edible fish species, withdrawal periods are varied in 5-30 
days, since fish are poikilotherms and their metabolic rate is 
determined by environment temperatures. In order to determine 
withdrawal period, the EU authorities require the trials that are 
conducted at least two water temperatures considered actual use of 
General Introduction 
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drug (Alderman, 1999; FAO/NACA/WHO, 1999).  Elimination time of a 
drug from fish is prolonged by low temperature because metabolic rate 
of animals conform to Q10 theory. When the value of Q10 in an animal 
is 2, metabolic rate of the animal is reduced by half compared to the 
rate at 10 C higher condition. The value of Q10 in almost edible fish 
species is around 2. This suggests that elimination time of drug would 
be prolonged twice at a maximum. Therefore, longish withdrawal 
period of each drug is determined.  
The European Union (EU) legislation which  is applied to the use 
of veterinary medicines in aquaculture relate to two main areas; one is 
marketing authorization (licensing) of the medicines and the other is 
control of residues in edible tissues.  European laws have two types; 
Regulations and Directives.  Regulations are law effective throughout 
the EU, and applied simultaneously in all Member countries.  Directives, 
in contrast, are one of the community laws, which Member countries 
must implement in their national legislation by a specified deadline.  In 
addition to Council Regulations, subsidiary Regulations made by the 
European Commission exist; these are modified primary regulations, 
and relevant examples of the regulation are shown in Annexes of 
Regulation 2377/90.  Such Commission Regulations comprise the 
majority of items of legislation relating to veterinary drugs (Alderman, 
1999). 
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The EU has established Maximum Residue Limits (MRLs) against a wide 
range of veterinary drugs (Council Regulation (EEC) No 2377/90), 
pesticides (Council Directives 86/363/EEC), and certain environmental 
contaminants (Commission Regulation (EC) 1881/2006).  For several 
substances which have been expressly prohibited from use in food 
producing animals in the EU (e.g. chloramphenicol, nitrofurans) and 
been not authorized (e.g. malachite green), the concept of the 
minimum requirement performance limits (MRPLs) has been 
established in Commission Decision 2002/657/EC. MPRLs are defined 
as ‘minimum content of a substance in a sample, which at least 
has to be possible to detect and confirm” (Commission Decision 
2005/34/EC).  MRPLs established against banned substances in fishery 
products are shown in Table 1.4. 
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Table 1.4 EU list of “Action level” for banned substances in food related 
to aquatic animal origin 
Substance and /or 
metabolite 
Matrices MRPL 
(µg/kg) 
Reference 
 
 
Chloramphenicol 
-Meat, Eggs, 
Milk, Urine, 
Honey 
-Aquaculture 
products 
 
 
0.3 
 
Nitrofuran metabolites 
(AOZ, AMOZ, AHD, 
SEM) 
-Poultry meat 
for all 
-Aquaculture 
products 
 
 
 
1.0 
 
 
 
Commission 
Decision 
2003/181/EC 
 
Some of malachite 
green and 
leucomalachite green 
 
-Meat of 
aquaculture 
products 
 
 
2.0 
 
Commission 
Decision 
2004/25/EC 
Source, EUROPA (2007) 
http://ec.europa.eu/food/food/chemicalsafety/residues/third_countris_
en.htm. 
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Japanese government implemented new regulations (“the 
Positive List System for Agricultural Chemical Residues in 
Foods”) on residues of agricultural chemicals in food since May 29, 
2006 to prohibit the distribution of foods that contain agricultural 
chemicals above a certain level. The “agricultural chemicals” include 
pesticides, feed additives and veterinary drugs. Implementation of the 
new regulation means that the former regulation based on “zero-
residue policy” has changed to the regulation based on “MRLs policy”.     
Ministry of Health, Labor and Welfare (MHLW) of Japan established 
provisional Maximum Residue Levels (MRLs) against 758 agricultural 
chemicals in addition to existing MRLs, and a uniform limit of 0.01 ppm 
against the chemicals that have not been established MRLs. The 
products containing harmful chemicals listed on “positive list” 
exceeding the MRLs or the uniform limit (0.01 ppm) cannot be 
distributed in Japanese market and could be rejected at the port in the 
case of imported products. 
(http://www.mhlw.go.jp/english/topics/foodsafety/positivelist060228/i
ndex.html) 
 
In the United States,   no food or feed item is distributed in the 
market legally if it contains a food additive or drug residue at 
unpermitted levels by The Food and Drug Administration (FDA).  FDA 
regulates safety on both domestic and imported foods and FDA has 
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primary responsibility for enforcing food safety laws including food 
import and export regulations for 80 percent of food supply (JSA, 
2007; Jahncke, 2007).  Drugs and chemicals used in the aquaculture 
are strictly regulated by various federal and state agencies, rules, 
regulations and guidance. Drugs used must be approved by the FDA’s 
Center for Veterinary Medicine (CVM) within the confines of the Federal 
Food Drug and Cosmetics Act -FFDCA, the basic food and drug law of 
the United State- (FFDCA; 21 U.S.C. 301-392).  Chemicals or 
pesticides used must be approved by the US Environmental Protection 
Agency (EPA). Pesticides are regulated under the FFDCA and the 
Federal Insecticide, Fungicide and Rodenticide Act (FIFRA; 7U.S.C. 
136-136y).    FDA’s Center for Food Safety and Nutrition (CFSAN) has 
unmasked unapproved drug residues such as chloramphenicol, 
nitrofurans, oxolinic and malachite green in both domestic and 
imported aquaculture products. The Food Safety and Inspection 
Service (FSIS) harmonized its procedures with those of FDA in respect 
to testing animal tissues for residues of new animal drugs to ensure 
that products containing unsafe levels of residues are not being 
released into market (JSA, 2007; Koonse, 2007; Oriani, 1999).   
Food Standard Australia New Zealand (FSANZ) has established 
by the Food Standards Australia New Zealand Act 
1991(http://www.foodstandards.gov.au/). In Australia and the New 
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Zealand, quality standards of food are working within an integrated 
food regulatory system.  FSANZ is part of the Australian Government’s 
Health and Ageing portfolio. FSANZ monitors the food supply in closer 
cooperation with the Australian Pesticide and Veterinary Medicines 
Authority (APVMA) in order to ensure appropriate use of chemicals in 
food production and conformity of foods to the standards established 
for microbiological contaminants, pesticide residue limits and chemical 
contamination.  Before agricultural or livestock products are distributed 
through market, the products must be approved by APVMA.  The 
APVMA approves the conditions of usage of chemicals by primary 
producers.  This attestation is enforced by Stat and Territory 
agriculture or environment agencies. The APVMA is also responsible to 
set the residue levels of chemicals which are allowed to be present in 
the final products.  These levels are expressed as maximum residue 
limits (MRLs). Recently, the MRLs of veterinary drugs in aquaculture 
products have been reported (NZFSA, 2008). 
http://www.nzfsa.govt.nz/policy-law/legislation/food-standards/nz-
mrl-fs-2008-consolidtion.pdf 
 
Since the nitrofurans crisis in 2002 (Pongvivat, 2004), the Thai 
government revised the existing legislation and regulations including 
import restrictions of 16 chemicals that were prohibited to use in 
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aquaculture in compliance with Annex IV of EU Council regulation 
(EEC) No 2377/90 (MRL regulation) and the USFDA list of banned 
drugs for food producing animals by Import and Export Act.B.E. 2522 
(1979). The objective of the revision was to ensure the traceability of 
any imports and restriction of drug usage for industrial and medical 
purpose only.  This includes following steps; 
- Development of a regulation  veterinary drugs usage and a 
proposal to improve Drug Act B.C. 2510 (1967) controlled  by 
Thai Food and Drug Administration, Ministry of Public Health. 
(http://www.fka.moph.go.th/eng/drug/intro.stm). 
- Ministry of Agriculture and Cooperatives, Department of 
Livestock Development is responsible for improvement of 
legislation and regulations on the control of importation and 
usage of animal feed and/or feed additives containing banned 
veterinary drugs  (including nitrofurans and chloramphenicol) 
under the Feed Quality Control Act B.C. 2522 (1979). 
- Improvement of a regulation on the standard of broiler farm 
by promotion of Good Animal Health and Husbandry Practices 
(GAHP) at farm level. 
- Implementation of the International Code of Practice for 
control the use of veterinary drugs by veterinarian in standard 
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farm accredited by the Department of Livestock Development 
(DLD) and the Department of Fisheries (DOF). 
- Improvement of legislation on veterinary profession and 
practice of veterinarian with morality; a veterinarian will have 
the license suspended if the veterinarian prescribes prohibited 
drugs. 
- Improvement of the regulation on facilitates inspection and 
sample collection for laboratory test in the slaughtering 
process. 
The Department of Fisheries (DOF) is responsible for regulation 
of 12 chemicals commonly used in aquaculture.  The import of these 
substances must be registered at the DOF (Tonguthai, 1996).  
 
Sources of residues in foods and food ingredients 
 
The residues of veterinary drugs in food may not be caused only 
by drug usage for chemotherapy (Mézes, 2007; Mantovani, et al., 
2006; McEvoy, 2002; Kennedy, et al., 2000).  Sources of residues of 
banned substances could be: 
- Historical use of the drug before a ban. 
- Intentional illegal use after ban, drug abuse. 
- Cross contamination from feed and feedstuffs. 
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- Environmental contamination from human activities or 
pet/aquarium fish medical use. 
- Contamination in the laboratory. 
- Contamination of chemicals used in manufacture processing. 
 
Residues of nitrofurans in food producing animals 
 
Nitrofurans are a group of synthetic antibacterial agents.  They 
have antibacterial and/or antiprotozoal activity and have been used 
extensively in fish and shrimp farming.  The nitrofurans are synthesis 
antibiotic characterized by their basic chemical structure i.e. a 
nitrofuran ring; 
 
- Furazolidone or 3-([(5-nitro-2-furanyl)methylene]amino)-2-
oxazolidinone 
- Furaltadone or 5-(morpholinomethyl)-3-[(5-
nitrofurfurylidene)amino]-2-oxazolidinone 
- Nitrofurantoin or 1-[(5-nitrofurfurylidene)amino] hydantoin 
- Nitrofurazone or 2-[(5-nitro-2-uranyl)methylene]-
hydrazinecaroxamine. 
 
Regarding furazolidone, it was shown that the detection of the 
parent drug is not feasible (McCracken et al., 1995; Nouws and 
General Introduction 
 
 22
Laurensen, 1990) because the parent drug is highly unstable in vitro 
and exhibits a very short half-life in vivo.  The drug is therefore not 
found as a residue.  It has proved that tissue bound metabolites are 
formed from parent drug in vivo; 3-amino-2-oxazolidinone (AOZ) is 
the free side chain of furazolidone, and more stable (Vroomen, et al., 
1986).  It can be detected in tissues of pigs for up to 7 weeks after 
withdrawal period of furazolidone (McCracken and Kennedy, 1997). 
According to the study of McCracken, et al. (2001), the concentrations 
of furazolidone and AOZ in eggs obtained from the bird treated with 
400 mg/kg furazolidone reached a plateau of ~360-380 µg/kg by the 
four days after treating. After a 4-day passed withdrawal period, intact 
furazolidone was not detected.  On the other hand, AOZ was still 
detected up to 21 days after treatment.  While the concentration of 
furazolidone in egg homogenates stored at -20°C decreases by 44% 
after 55 days, AOZ residues are stable during this period.  From these 
results, AOZ is a suitable marker for the monitoring of furazolidone 
residue. Similarly, side-chain regions of other nitrofurans form the 
metabolites of parent drugs and serve as a monitoring marker for 
residues.   The chemical structures of all metabolites are shown in Fig 
1.1.  
Auro et al. (2004) evaluated the carcinogenic effect of 
furazolidone in two fish species.  They reported that administration of 
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AOZ at dose of 11 mg furazolidone/kg feed/day for 12 weeks tend to 
cause tumors in mollies (Poecilia Formosa).   The liver steatosis was 
observed in all samples from furazolidone-treated fish.  From week 3 
to the end of the experiment, melanohistocytomes in liver, pancreases, 
kidney and gonad from treated fish were increased obviously.  A 
similar trial was carried out in tilapia (Oreochromis niloticus) by adding 
50 mg furazolidone/kg into the feed for 90 days.  No tumors were seen 
in any of the furazolidone-treated tilapias while hepatic steatosis was 
found in all furazolidone-treated fish.    
 
 
Characteristics of furazolidone metabolites 
 
  Hoogenboom, et al. (2002) revealed that free AOZ were detected 
in the blood of pigs treated with furazolidone at dose of more than 0.3 
µg/mL.  It is also shown that the AOZ could be released from both the 
parent drug and protein-bound residues under mild acidic condition by 
cleavage of the azomethine bond.  There is a possibility that AOZ will 
be metabolized into the carcinogen; 2-hydroxyethylhydrazine 
(HEH)(Hoogenboom, et al., 1991).  AOZ showed positive response in 
the Salmonella/microsome mutagenicity test in tester strains TA1535 
and TA100.  Furthermore, a positive response was obtained in the 
chromosome aberration test with human lymphocytes and bone 
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marrow micronucleus test with the mice treated intraperitoneally with 
AOZ.  These data suggests that metabolite of furazolidone (AOZ) may 
be a compound with potential genotoxic properties (Hoogenboom et al., 
2002). Although the carcinogenesis of nitrofurans metabolites has not 
been proved completely, the residues of nitrofurans including its 
metabolites in food are controlled strictly in food importing countries 
such as EU, USA and Japan. 
 
Outline and objectives of the thesis 
 
Aquaculture products have always a potential to be contaminated 
by chemical substances either from direct or indirect sources 
mentioned above.  These potential problems can occur on the farm, 
processing factories or at the wholesale/retail levels. Responsibility for 
food safety associated with products from aquaculture must be shared 
between governments, the fish farmers and processors and also 
consumers (FAO, 1997). The aquaculture sector should institute 
appropriate farm management programs based on the principle of the 
HACCP system (FAO/NACA/WHO, 1999; Reilly and Käferstein, 1997).  
While the implementation of safety control based on HACCP 
system is well advanced in the fish processing sector, the application of 
such safety control to the fish farm is still only in its infancy.   Several 
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problems arise when its concept and methods are applied without 
modification to an aqua farm (Maita, 2007).  However, national and 
international agencies continue to recommend and promote the 
implementation of HACCP throughout all stages of food production.  In 
order to promote hygienic control based on HACCP system in fish farm, 
concept and methods of hygienic control should be modified. However, 
the modification must be based on the scientific data.   
Recently, under the strengthening measures for the assurance of 
food safety on agriculture chemical residues, the Ministry of Health, 
Labour and Welfare (MHLW) of Japan reported the cases of violation 
against the Food Sanitation Law that were found on the occasion of 
quarantine (Fig 1.2).  This evidence revealed that antibiotics residues 
still be serious issues concerning the public health. The major types of 
antibiotics residues occurred in aquatic animals imported into Japan 
are banned chemicals such as Nitrofurans, Malachite green and 
Leucomalachite green, Chloramphenicol and Tetracycline. The violation 
cases of AOZ residue have been reducing; however, it is still found 
continuously (Fig 1.3) both in live and processed eel products.  
In order to manage the risk of AOZ residue properly in farmed 
eel, it is necessary to obtain the scientific knowledge regarding 
pharmacokinetics and metabolism of furazolidone. However, the 
essential scientific data in Japanese eel lack. The main objective of this 
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thesis is to obtain the essential scientific data to support the chemical 
risk management on AOZ residue in Japanese eel.  
In Chapter 2, verification of the rapid analytical method that 
would be adopted for the monitoring of AOZ residue was examined. 
Continued Chapter 3, the clearance of AOZ from muscle and liver in 
Japanese eel was investigated in view point of pharmacokinetics. The 
evaluation of drug-metabolizing enzymes related to AOZ excretion was 
carried out (Chapter 4), Finally, I attempted to enhance AOZ excretion 
from fish tissues by feed additive as a countermeasure against 
unexpected residue of AOZ (Chapter 5).  
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Figure 1.1 Chemical structures of various nitrofurans and its 
                metabolites. 
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Figure 1.2 Number of violation of veterinary drug residues in aquatic 
animals imported into Japan. Achieved data resulted from fiscal year 
2004 until 2007. (Data in parenthesis indicates the percentage of 
violation in aquatic products;*data reported until December 2007). 
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Violation of AOZ in eel products imported into 
Japan
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Figure 1.3 Recent violation cases of AOZ residue found in imported eel 
products into Japan reported by MHLW. (*data reported until 
December 2007). 
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Chapter 2 Verification of ELISA-based kit for detecting 
furazolidone metabolite (AOZ) in eel 
 
Abstract 
 
It is difficult to detect residual furazolidone because it is readily 
metabolized in animal tissues but, its metabolite, 3-amino-2-
oxazolidinone (AOZ) can be detected by using LC-MS/MS. However, 
measurement of AOZ by LC-MS/MS has some problems. In this study 
describe the validity of an ELISA kit to detect AOZ in Japanese eel 
(Anguilla japonica) tissue.  This ELISA is capable of detecting AOZ at 
1.0 µg/kg in an eel sample with excellent accuracy and precision. 
These results show that the ELISA method is suitable for regulatory 
purposes and for studying the fate of AOZ residues in eel treated with 
furazolidone.  
 
Introduction 
 
Furazolidone is difficult to detect because residues of the parent 
drug are highly unstable in vitro and exhibit a very short half-life in 
vivo (McCraken, et al., 1995).  The drug is therefore not found as a 
residue or is detected only at very low concentrations after treatment. 
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However, the free side chain of furazolidone – namely, AOZ (3-amino-
2-oxazolidinone), which is the metabolite moiety derived from 
furazolidone – is more stable (Vroomen, et al., 1986). It has been 
suggested that AOZ can be metabolized into β-hydroxyethylhydrazine, 
which is a mutagenic and carcinogenic compound (Hoogenboom, et al., 
1991).  Therefore, AOZ has become a target substance for monitoring 
and regulating furazolidone residues in food.  In Japan, the Food 
Sanitation Law requires that nitrofuran residues in food should be less 
than the detection limits of the analytical methods approved by the 
Ministry of Health Labor and Welfare. In the case of AOZ, the detection 
limit for the LC-MS/MS method has been set at 1 µg/kg. Measurement 
of AOZ by LC-MS/MS has some problems. Some testing laboratory 
reported that recovery of LC-MS/MS is not stable sometimes then the 
internal standard (IS) is used as well as in case the recovery of IS has 
been below 50 %, they re-analyze AOZ residue again from the 
beginning of procedure (personal communication). In addition, the cost 
of examination is too expensive. These problems cause insufficient 
frequency of monitoring of AOZ residue. 
Enzyme-linked immunosorbent assay (ELISA) is an effective 
alternative to analytical detection and monitoring methods that offers a 
fast, reliable and relatively cheap way to determine low concentrations 
of target analytes.  For example, polyclonal antibodies, which were 
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incorporated into an immunoassay for the detection of AOZ after its 
derivatization with ο-nitrobenzaldehyde (ο-NBA), have been produced 
and used in prawn analysis by Cooper, et al. (2004ab). A simplified but 
still sensitive ELISA based on a monoclonal antibody immunoassay 
(Diblikova, et al., 2005) has also been used to determine AOZ in 
shrimp, poultry, pork and beef as well as in poultry eggs (Franek, et al., 
2006).  
The aim of this study is to verify whether an ELISA method can 
accurately measure AOZ in eel tissues, frequent monitoring of AOZ 
residue by that will become possible to assure the safety of farmed eel.  
 
Materials and methods 
 
1. Chemicals 
RIDASCREEN® Nitrofuran (AOZ):- a competitive enzyme 
immunoassay for the quantitative analysis of AOZ- was a product of R-
Biopharm AG, Germany.  AOZ Spike-solition 20 ng/ml in Methanol was 
purchased form R-Biopharm.  Unless otherwise indicated, chemicals 
used were analytical grade from Wako, Japan. 
 
2. Verification of ELISA for the quantification of AOZ 
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 AOZ concentration in blank eel samples were analyzed by ELISA 
method.  Recovery of spiked AOZ was calculated as Cm/Cs X 100, 
where Cm and Cs are the measured and spiked AOZ concentrations, 
respectively.  Precision, recovery and repeatability of the ELISA were 
determined by using blank samples spiked at levels of 1 and 2 µg/kg 
on different days.  All data are presented as the mean ± SD, significant 
differences were examined using ANOVA followed by t-test from 
Microsoft Excel program.  
 
3. Performance of ELISA in comparison with confirmatory LC-MS/MS 
method 
Japanese eel (Anguilla japonica) were immersed in 20 mg/L 
furazolidone for 2-3 hours and then maintained in an earth pond for 6 
days without furazolidone and immersed in 2 mg/L for 160 days.  Fish 
were sacrificed and muscle samples were taken.  Muscle tissue of each 
sample was chopped and homogenized then divided into two portions 
and then stored at -20°C until use. One portion was used for ELISA and 
the other was commissioned of Japan Food Research Laboratories 
(JFRL) to analyze AOZ concentration by LC-MS/MS.  
 
4. Extraction procedure  
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Chopped and homogenized eel samples were weighed (1.00 + 0.01 
g) into glass tubes with stopper.  When required, samples were spiked 
by addition of 50 µl AOZ standard solution (20 ng/ml) in methanol to 
give spiking equivalent to 1.0 µg AOZ/kg eel tissue. Water (4 ml), 
Hydrochloric acid (1 M, 0.5 ml) and ο- nitrobenzaldehyde (o-NBA; 10 
mM solution in DMSO, 100 µl) were added to each tube and shaken 
properly.  Sample tubes were incubated for 16 h (overnight) at 37 oC.  
The pH of all samples was adjusted to 7 – 8 by addition of 5 ml K2HPO4 
0.1 M and adjustment with 1 M sodium hydroxide 0.4 ml.  Ethyl 
acetate (10 ml) - which minor modified from R-Biopharm leaflet, 
Art.No.:R3701) - was added to each tube, mixed vigorously for 30 sec. 
and centrifuged for 10 min at 3000g at room temperature (20 – 25 oC).  
The upper ethyl acetate layer (2 ml) was transferred to a clean glass 
tube and evaporated to dryness at 40 oC. Residues obtained following 
the extraction were dissolved by addition of n- hexane (4 ml) and 
sample buffer (2 ml) and centrifuged at 3000 g at ambient 
temperature (20 – 25 oC) for 10 min.  The lower layer (50 µl) was used 
for immunoassay procedure. 
 
5. Immunoassay procedure (ELISA test) 
The basis of the test is the antigen-antibody reaction (R-Biopharm 
leaflet, Art. No.: R3701).  The microtiter wells -coated with capture 
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antibodies directed against anti-AOZ antibodies- were insert into the 
microtiter plate. Fifty microliters of each AOZ standards or sample 
solution were added to separate duplicate wells and the AOZ enzyme 
conjugates (50 µl) were added to the bottom of each well. Anti-AOZ 
antibodies (50 µl) were added and mixed gently by shaking the plate 
manually and incubated for 1 h at room temperature (20 – 25 oC). 
Free AOZ and AOZ enzyme conjugate compete for the AOZ antibody 
binding sites (competitive enzyme immunoassay).  At the same time, 
the anti-AOZ antibodies are also bound by the immobilized capture 
antibodies.  After incubation any unbound enzyme conjugate is then 
removed in a washing step by pour the liquid out of the wells and tap 
the microtiter plate upside down vigorously (three times in a row) 
against absorbent paper to ensure complete removal of liquid form the 
wells. 250 µl of washing buffer were filled in all wells and pour out the 
liquid again (repeat two more times). Substrate/chromogen (100 µl) 
was added to the wells and mixed gently by shaking the plate 
manually and incubated for 15 min at room temperature (20 – 25 oC) 
in the dark.  Bound enzyme conjugate changed the chromogen into a 
blue product. 100 µl stop solution were added and led to a color 
change from blue to yellow.  Absorbance values were measured at 450 
nm and the concentration of the analyte in a sample was calculated 
from calibration curve by the RIDA® SOFT Win software. 
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Results and Discussion 
 
Table 2.1 presents calculated the limit of detection and measured 
values of blank eel samples spiked with AOZ at the level of detection 
capability for ELISA method. Because of matrix interference, AOZ-free 
eel tissues gave a weak positive ELISA signal, corresponding to an AOZ 
concentration of 0.227 + 0.237 µg/kg (n=24). In this study the 
extraction procedure was modified in little to rid lipid interference of 
eel samples.  The limit of detection (LOD) here defined is the 
concentration of average blank eel samples plus 3 times the standard 
deviation. The procedure allowed the limit of detection (LOD) in eel 
samples closely to 1.0 µg/kg (0.938 µg/kg).  The average AOZ 
recovery values obtained in blank eel samples spiked with AOZ at 
levels of 1.0 µg/kg (n=5) defined as the detection capability was 
87.7 % and coefficients of variation was 12.7 %. Although these data 
shown higher level of LOD than previous studied in prawn tissue by 
Cooper, et al. (2004b), it is still in compliance with the Minimum 
Required Performance Limits (MRPL) of the LC-MS/MS method for 
nitrofuran metabolites at 1.0 µg/kg.    Therefore the sensitivity of 
ELISA would be enough to use for screening of AOZ residue. 
Among days 1, 2 and 3, the mean concentrations of the samples 
spiked at 1 µg/kg were close to the spiked values and were not 
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significantly different (p>0.05) (Table 2.2). Between days 1 and 2, the 
mean concentrations of the samples spiked at 2 µg/kg were somewhat 
lower than the spiked values but the two values were not significantly 
different (p>0.05) (Table 2.2).  The coefficient of variation ranged 
from 6.11 to 23.03 % for the samples spiked at 1 µg/kg, and from 
5.22 to 14.35 % for those spiked at 2 µg/kg.  The corresponding 
accuracies of 1 µg/kg and 2 µg/kg defined as the % recovery, were 97 
– 102 % and 77 – 91 %, respectively. In this study, recovery of spiked 
AOZ in eels was fair in comparison with the recovery reported in fish 
(51 – 85 %) by Diblikova, et al. (2005).  Precision, accuracy and 
repeatability of ELISA would be satisfactory for screening of 
furazolidone metabolite (AOZ) in eel tissues. 
Table 2.3 demonstrates the performance of the ELISA kit in 
comparison with a confirmatory method by LC-MS/MS for the 
determination of AOZ in eel samples.  The AOZ levels measured by 
ELISA (25 to 38 µg/kg) were comparable to those measured by LC-
MS/MS (34 to 51 µg/kg) (Table 2.3). The values of samples measured 
by ELISA were ranged 55 to 81% (mean 70%) of that by LC-MS/MS. It 
was revealed that AOZ concentrations measured by our ELISA method 
tended to underestimate the values determined by LC-MS/MS. 
Similarly, in prawns, AOZ levels measured by ELISA were only 21 – 
47 % of those measured by LC-MS/MS (Cooper, et al., 2004b).  The 
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underestimation in current study probably reflects the efficiency of 
AOZ and ο-nitrobenzaldehyde (ο-NBA) derivatization and extraction 
steps of our ELISA method in which NPAOZ standard was used as an 
external standard. It is also considered that dilution factors for sample 
preparation may relate to the underestimation of ELISA method. AOZ 
concentrations in incurred eel samples in this study were exceed the 
maximum concentration of calibration standard (4 µg/kg). The 
optimum dilution factor should be selected for sample preparation 
when the sample containing high concentration of AOZ is measured. 
Underestimation by ELISA method would lead to the false-
negative at the levels of LOD. In fact, false-negative was observed in 
our study as shown in Table 2.3. In order to avoid the likelihood of 
false-negative in the analysis, quality control comprising an eel sample 
blank and an eel sample blank spiked with standard AOZ at a level of 
LOD (1 µg/kg), should be included in every analysis. In addition, the 
negative sample that AOZ level detected more than 0.8 µg/kg by the 
ELISA method should be reanalyzed by the confirmatory method LC-
MS/MS.  
Although AOZ concentrations measured by our ELISA method 
showed underestimation for the values from LC-MS/MS, the ELISA-
determined concentrations were highly correlated with the LC-MS/MS-
determined values. A plot of ELISA- and LC-MS/MS-determined 
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concentrations of AOZ in eel muscle tissues at various sampling times 
after exposed to 2 mg/L of furazolidone yielded a regression equation 
(r = 0.993) which was shown in Fig. 2.1.  
 All of verification data in this Chapter clearly demonstrate that the 
ELISA method can be used to detect the presence of AOZ in muscle 
tissues of eels treated with furazolidone. The presence of residual 
furazolidone metabolite (AOZ) in the human food chain has become an 
area of widespread public concern in recent years and, although there 
is some disagreement on the in vitro and in vivo toxicity of AOZ (Auro, 
et al., 2004; Hoogenboom, et al., 2002; Ali, 1999; Klee, et al., 1999; 
McCraken, et al., 1995), the possibility that it is unsafe cannot be 
excluded at present.  Therefore, it is necessary to monitor foods 
carefully for the presence of AOZ. There is now an urgent need for 
rapid and high capacity screening methods for tissue-bound residues of 
furazolidone in animal food products.  ELISA method that offers the 
advantage of analytical time and cost efficiency will be hopefully 
adopted for screening the residues of furazolidone metabolite. 
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Table 2.1 Limit of detection and determination of AOZ in spiked 
samples by using ELISA kit  
 ELISA kit 
 
Representative blank samples (n) 
Mean + sd (µg/kg) 
LOD (mean + 3sd; µg/kg) 
 
Spiked samples (n) 
AOZ spiked (µg/kg) 
Mean + sd (µg/kg) 
Recovery (%) 
Coefficient of variation (CV; %) 
 
24 
0.227 + 0.237 
0.938 
 
5 
1.00 
0.877 + 0.111 
87.7 
12.7 
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Table 2.2 Precision, recovery and repeatability of ELISA kit for AOZ 
determination in eel tissues 
Spiked 
level 
(µg/kg) 
 
day 
 
n 
 
Mean + sd 
 (µg/kg) 
 
CV (%) 
 
Recovery 
(%) 
 
 
1 
 
1 
2 
3 
 
4 
4 
4 
 
1.016 + 0.234 
0.999 + 0.061 
0.971 + 0.119 
 
23.03 
6.11 
12.25 
 
101.6 
99.9 
97.1 
 
 
2 
 
1 
2 
 
 
4 
4 
 
 
1.534 + 0.080 
1.819 + 0.152 
 
 
5.22 
8.36 
 
 
76.7 
91.0 
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Table 2.3 Concentrations of AOZ detected by enzyme linked 
immunoabsorbent assay (ELISA) and liquid chromatography coupled 
with tandem mass spectrometry (LC-MS/MS) in Japanese eel exposed 
to furazolidone  
 
AOZ conc. (µg/kg) Eel sample Sample 
No. ELISA LC-MS/MS 
Ratioc 
(%) 
1 27.39 34 81 
2 30.55 42 73 
3 34.36 43 80 
4 31.65 51 62 
5 25.46 46 55 
6 28.78 48 60 
 
 
aExposed  
in 20 mg/L 
7 38.81 48 81 
bNegative 
sample  
in 2 mg/L 
1 
2 
3 
4 
< 1 (0.87) 
< 1 (0.92) 
< 1 (0.99) 
< 1 (0.87) 
1 
ND 
ND 
ND 
 
 
- 
a Eels were immersed in 20 mg furazolidone/L for 2 h and then 
transferred to an earth pond for 6 days before analysis. 
b Negative eel samples obtained on day 146 after immersion in 2 mg 
furazolidone/L in 2 mg furazolidone/L in the AOZ-elimination 
experiment. 
c AOZ conc. from of ELISA /AOZ conc. from of LC-MS/MS x 100. 
ND = not detected. 
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Figure 2.1 Correlation of AOZ concentration in Japanese eel muscle 
tissues obtained by ELISA and LC-MS/MS at sampling times of 28, 42, 
56, 101, 118, 132, 146 and 160 days after immersion.  The regression 
equation for ELISA is y = 0.496 + 0.8166x (r = 0.993, n = 8). 
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Chapter 3 Application of ELISA for AOZ clearance from 
eel and tilapia 
 
Abstract 
 
To measure the persistence of AOZ in eel tissues, eels (1.4 to 6.5 g) 
were immersed in tanks containing 2 and 10 mg furazolidone/L for 3 
hours, and then maintained in a tank supplying well water for the next 
160 days.  The half-lives of AOZ, calculated from the linear terminal 
part of the excretion curve, were 25.0 days in muscle and 21.6 days in 
liver from fish exposed to 2 mg furazolidone/L.  In the eels treated 
with 10 mg furazolidone/L, by contrast, high levels of AOZ were 
detected in liver and muscle, but the half-lives of AOZ were similar to 
those in fish treated with 2 mg/L.  The half-lives of AOZ in eel tissues 
were prolonged by the condition of low water temperature. 
The residue of AOZ in Nile tilapia was conducted by immersion as same 
as Japanese eel. The half-lives of AOZ in tilapia muscle and liver were 
5.42 and 4.75 days, respectively. Elimination time of AOZ from tilapia 
tissues was shorter obviously in comparison with Japanese eel. 
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Introduction 
 
Furazolidone is difficult to detect because residues of the parent 
drug are highly unstable in vitro and exhibit a very short half-life in 
vivo (McCracken, et al., 1995).  The drug is therefore not found as a 
residue or is detected only at very low concentrations after treatment. 
However, the free side chain of furazolidone – namely, AOZ (3-amino-
2-oxazolidinone), which is the metabolite moiety derived from 
furazolidone – is more stable (Vroomen, et al., 1986). It has been  
All foods distributed in the Japanese market are subject to the 
Food Sanitation Law. Foods found to contain chemicals for which no 
maximum residue limits (MRLs) have been set - for example; 
nitrofurans, chloramphenical, leucomalichite green, and so on - are not 
allowed to be sold.  The most recent cases found to violate this law in 
Japan involved residues of AOZ in eel and shrimp imported from China 
and India (Ministry of Health, Labor and Welfare, 2006ab) and residues 
of leucomalachite green in amberjack produced in domestic fish farms. 
The residues of leucomalachite green, a metabolite form of a cationic 
triphenylmethane dye (malachite green has been used worldwide as a 
fungicide and extoparasicide in cultured fish eggs), found in farmed 
amberjack were traced to contaminated feed. This finding shows that it 
is important to monitor and to manage veterinary drug residues even 
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when they are prohibited for use in aquaculture.  However, banned 
drugs may also be introduced through contaminated feed, 
contaminated rearing water or transfer between animals. In order to 
monitor the risk of AOZ residues in eel properly, it is necessary to 
determine the clearance time of these residues. In fish, there is a 
report on elimination of AOZ only in tilapia (Xu, et al., 2006). At 
present, little information is available on the presence of AOZ residues 
in eel tissues.  
The aim of this study was to determine how long it takes AOZ 
residues to be eliminated from eel in comparison with tilapia. 
 
Section I; Residue of AOZ in eel tissues 
 
Materials and Methods 
 
1. Chemicals 
The RIDASCREEN® Nitrofuran (AOZ) kit, a competitive enzyme 
immunoassay for the quantitative analysis of AOZ was a product of R-
Biopharm AG, Germany.  The AOZ spike solution (20 ng/mL in 
methanol) was purchased from R-Biopharm.  Unless otherwise 
indicated, the chemicals used were analytical grade from Wako Pure 
Chemical Co. Ltd, Japan. 
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2. Fish  
Wild juvenile Japanese eel Anguilla japonica weighing about 0.5 g 
were caught on the coast around Japan.  They were transported to 
Yoshida Field Research Center of Tokyo University of Marine Science 
and Technology and stocked in a 1.5-ton FRP tank with recirculation 
system for several months and used for these experiments. 
Japanese eels weighing 1.4 to 6.5 g were kept in two 1.5-ton FRP 
tanks. Tanks were supplied with well water at the rate of 1.2 L/min. 
The average weights of fish in the two tanks were 4.21 g and 4.25 g, 
and the numbers of fish were 451 and 461, respectively. Fish were fed 
twice a day at a rate of 1% body weight.  For furazolidone treatment, 
the water supplies to the tanks were turned off and furazolidone was 
added to a final concentration of 2 and 10 mg/L, respectively. The 
water temperature during the experiment was 23.1 + 1.5 °C.  After 3 h, 
the water supply was turned on again. Muscle samples were taken at 
various times between 3 h and 160 days.  At each sampling time, 10 
fish were sacrificed to obtain muscle and liver samples.  The muscle 
samples were divided into five pairs and the samples in each pair were 
pooled to form five replicates.  All ten liver samples were pooled to 
form one replicate.  Samples were stored at -20°C until use.     
At 101 days after exposure to furazolidone, half of the fish in each 
tank were transferred to a separate low temperature tank (18.8 + 
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0.8 °C).  The other half were left in the high temperature tank (23.1 + 
1.5 °C). 
 
3. Extraction procedure for ELISA 
Chopped and homogenized eel tissue samples were weighed (1.00 
+ 0.01 g) into amber glass tubes with stoppers.  Quality control eel 
samples were used to provide data to assess the likelihood of false-
positive in the analysis. The quality controls in this study, comprising 
an eel sample blank and an eel sample blank spiked with standard AOZ 
at a designated dose, were included in every analysis. Blank samples 
were spiked by the addition of 50 µL of AOZ standard solution (20 
ng/mL) in methanol to obtain 1.0 µg AOZ/kg eel tissue. Water (4 mL), 
Hydrochloric acid (1 M, 0.5 mL) and ο-nitrobenzaldehyde (ο-NBA; 10 
mM solution in DMSO, 100 µL) were added to each tube.  The tubes 
were vigorously shaken and incubated for 16 h (overnight) at 37 °C.  
The pH of all samples was then adjusted to 7 – 8 by the addition of 5 
mL of 0.1 M K2HPO4 and 0.4 mL of 1 M sodium hydroxide.  Ten 
milliliters of ethyl acetate (slightly modified as described in the R-
Biopharm leaflet, Art.No.R3701) was added to each tube.  The tubes 
were mixed vigorously for 30 s and centrifuged for 10 min at 3000 x g 
at room temperature (20 – 25 °C).  The upper ethyl acetate layer (2 
mL) was transferred to a clean glass tube and evaporated to dryness 
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at 40 °C. The residue obtained after the extraction was dissolved by 
the addition of n- hexane (2 mL) and sample buffer (1 mL; 10mM 
phosphate buffer, pH 7.4 containing 0.05% Tween 20), and 
centrifuged at 3000 x g at ambient temperature (20 – 25 °C) for 10 
min.  The lower layer (50 µL) was used in the immunoassay procedure 
(R-Biopharm leaflet, Art.No.R3701).  The productions of polyclonal 
antibodies specific for the nitrophenyl derivative of AOZ have been 
described by Cooper, et al. (2004), these antibodies are highly specific 
for the nitrophenyl derivative of AOZ (NPAOZ).  No significant cross-
reactivity (<0.01%) was seen with nitrofuran metabolites AMOZ, AHD 
or SEM (their nitrophenyl derivatives NPAOZ, NPAHD or NPSEM), the 
derivatizing agent ο-nitrobenzaldehyde (ο-NBA), the parent nitrofuran 
drugs furaltadone, nitrofurantoin or nifursol, or a range of five 
nitroimidazole, two tetracycline and two sulphonamide drugs.  Minimal 
cross-reactivity (<1%) was seen with AOZ and nitrofurazone.  
Significant cross-reactivity (35.2%) was seen only with furazolidone. 
The absorbance values obtained from the standards and the samples 
were calculated by RIDA®SOFT Win.  In order to determine the 
concentration of AOZ in a sample, the concentration readout from the 
calibration curve was multiplied by the corresponding dilution factor. 
The eel tissues in this study were extracted with our modified 
procedure as described above; therefore, the dilution factor was 5. 
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Results 
 
In each series of analyses, the recovery of quality control eel 
sample was more than 80%. 
The clearance of AOZ residues in muscle and liver tissues of eels 
treated with 2 and 10 mg/L furazolidone is shown in Fig 3.1 (A-D).  In 
fish exposed to 2 mg/L furazolidone, the muscle AOZ concentration 
peaked at 360.56 + 46.03 µg/kg at 48 h and the liver AOZ 
concentration peaked at 1,578.98 µg/kg at 24 h.  It should be noted, 
however, that residual furazolidone was still present in the tanks at 
these time points.  At the end of the experiment (160 days), AOZ 
residues in muscle tissues were significantly lower than the limit of 
detection (LOD = 1 µg/kg).  However, AOZ in eel liver (1.022 µg/kg) 
remained above the limit of detection. In all eel samples taken until 96 
h after immersion in 10 mg furazolidone/L, AOZ residues were higher 
than the analytical range of this method.  At the end of the experiment, 
AOZ concentrations in muscle (2.71 + 0.67 µg/kg) and liver (2.74 
µg/kg) were still significantly above the LOD.  
The half-lives of AOZ, calculated by fitting an exponential equation 
to the linear terminal part of the excretion curve of data obtained from 
day 7 after immersion until the end of experiment (Table 3.1), were 
shorter in the liver than in the muscle tissue of Japanese eel.  The 
Application of ELISA for AOZ clearance from eel and tilapia 
 
 64
elimination of AOZ in Japanese eel muscle was slower at low water 
temperature (Fig 3.2).  
   
Discussion 
 
AOZ residues have been found to be difficult to eliminate from Nile 
tilapia, Oreochromis niloticus (Xu, et al., 2006) and shrimp, 
Litopenaeus vannamei (Chu and Lopez, 2005). Sixteen days after 30 
mg furazolidone/kg was orally administered to tilapia, the AOZ 
concentration in muscle was 2 µg/kg.  Similarly, 72 hours after 
exposing shrimp to 0.25 mg/L furazolidone for 16 h, AOZ residues 
were detectable in the muscle. The presence of AOZ in aquacultural 
products is probably due to the administration of small amounts of 
furazolidone for therapeutic and prophylactic reasons. Even when 
young eels are given a single dose of furazolidone, AOZ residues 
remain detectable in the edible tissues of eels for almost six months.  
Any treatment taking place after that life stage of the Japanese eel 
may lead to public health concerns over the presence of residues that 
are against the law at any concentration. 
The slower elimination of AOZ in eels kept at lower temperature 
suggests that water temperature is an important factor affecting AOZ 
residues in Japanese eel tissues. Thus, water temperature should be 
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taken into consideration during monitoring and risk management of 
AOZ residues.  Our results are consistent with previous reports that 
AOZ concentrations are several times higher in liver tissue than in 
muscle tissue (Hoogenboom, et al., 1992; McCracken, et al., 1997 and 
2005; McCracken and Kennedy, 1997; and Cooper, et al., 2005).  
Moreover in all cases, the half-life of AOZ was shorter in liver than in 
muscle. These results agree with measurements of AOZ half-life in pig 
liver and muscle (McCracken, et al., 1997 and Cooper, et al., 2005).  
In the present study, we determined the half-life of AOZ in Japanese 
eel tissues. Knowing the half-lives of AOZ in animal tissues will make it 
easier to estimate the elimination time.  On the basis of the elimination 
time, a period can be fixed during which harvesting the animals should 
be prohibited.  This control method will be beneficial for the risk 
management of unexpected AOZ residues in eel.  A proper risk 
management program for preventing the occurrence of AOZ residues 
in eel products should be established.  
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Figure 3.1 AOZ concentrations in Japanese eel after immersion 
        of 2 mg/L in muscle (A), liver (B). 
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Figure 3.1 (cont) AOZ concentrations in Japanese eel after 
        immersion of 10 mg/L in muscle (C) and in liver (D). 
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Table 3.1 Half-life of AOZ in the tissues of Japanese eel immersed in 
furazolidone (2 and 10 mg/L) at a water temperature of 23 °C 
 
Equation 
y=C0exp(-kt)* 
 
Tissue 
 
Dose 
(mg/L) C0  
(µg/kg) 
k  
(day-1) 
 
Correlation 
coefficient 
(r) 
 
Half-life 
(days) 
 
2 
 
42.904 
 
0.0277 
 
0.969 
 
25.0 
 
Muscle 
 
10 
 
139.02 
 
0.026 
 
0.956 
 
26.6 
 
2 
 
118.73 
 
0.321 
 
0.962 
 
21.6 
 
Liver 
 
10 
 
412.69 
 
0.0317 
 
0.975 
 
21.9 
*y = concentration after time t, C0 = initial concentration (t=0),  
k = elimination rate. 
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Figure 3.2 Elimination curve of AOZ in Japanese eel muscle tissues 
exposed to 2 mg/L furazolidone at high (23.1°C; □) and low 
(18.8 °C; ▲) temperatures. The half-lives of AOZ calculated by 
exponential equation was 25.6 and 29.4 days at high and low 
water temperatures, respectively.  The exponential equation for 
high temperature is y = 34.318e-0.0253x (r2 = 0.9791) and the 
exponential equation for low temperature is y = 28.924e-0.0214x  
(r2 = 0.9865). 
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 Section II; Residue of AOZ in tilapia tissues 
 
Materials and Methods 
 
1. Chemicals 
As mentioned in eel section. 
 
2. Fish  
Nile tilapia (Oreochromis niloticus), ranging in mass from 5.8 to 
9.4 g, were acclimated in aquariums supplied with stocked tap water at 
flow rate of 1.2 L/min in the Laboratory of Fish Health Management, 
Tokyo University of Marine Science and Technology for 2 weeks.  Fish 
were fed twice a day at a rate of 1% body weight.  For furazolidone 
treatment, the water supplies to aquariums were turned off and 
furazolidone was added to a final concentration of 2 mg/L. The water 
temperature during the experiment was 28 + 0.6 °C.  After 3 h, the 
water supply was turned on again. Samples were taken at various 
times between 3 h and 42 days.  At each sampling time, 7 fish were 
sacrificed to obtain muscle and liver samples.  All seven liver samples 
were pooled to form one replicate.  Samples were stored at -20°C until 
used.  Measurement of AOZ residue in tilapia tissues were conducted 
by ELISA as mentioned in eel section. 
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Results 
 
Elimination of AOZ in muscle and liver tissues of tilapia with the 
passage of time after immersion of 2 mg furazolidone/L were shown in 
Fig 3.3.  Data were not obtained on liver samples at 1, 2 and 7 day 
since these samples were lost. At three hours after immersion, AOZ 
concentration reached to the maximum level; 335 ± 155 and 606.21 
µg/kg in muscle and liver, respectively. The concentrations of AOZ in 
both tissues were below 1.0 µg/kg after 42 days after exposure.  
Concentrations of AOZ in liver were greater than those in muscle.  The 
half-lives of AOZ were a bit shorter in the liver than in the muscle 
tissue of Nile tilapia (Table 3.3). 
 
Discussion   
 
Tilapia was exposed to furazolidone at the same condition in 
Japanese eel except for water temperature. Although water 
temperature is one of important factor affecting to the elimination of 
AOZ (Chapter 3, section I), water temperature was selected 
considering the optimum rearing temperature for each species. 
Therefore, it is considered that the differences of AOZ elimination in 
both species are able to compare.  
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While the distribution of AOZ in tilapia, i.e. concentrations of AOZ 
in liver were greater than those in muscle and the half-life of AOZ in 
liver was a bit shorter than those in muscle tissue, was similar to 
Japanese eel, the half-lives of AOZ in tilapia tissues were shorter than 
those of Japanese eel obviously. This could result from differences in 
the drug uptake, the absorption of the drug, and metabolic and 
elimination capabilities in the fish.  The source of this variation has not 
yet been analyzed systematically.  It is considered that different drug 
uptake could be the most important contributing factor of the drug 
(Chen, et al., 2004 and Shaikh, et al., 2003). It is necessary to 
investigate the difference on pharmacokinetics and the activities of 
drug metabolism of AOZ between Tilapia and Japanese eel. The 
knowledge will be useful to establish proper countermeasures to 
control AOZ residue in Japanese eel. 
The elimination of AOZ from tilapia tissues by bath treatment took 
longer time compared to those of oral administration reported by Xu, 
et al. (2006). In section I, it was revealed that the half-lives of AOZ in 
Japanese eel were almost the same regardless of the dose of 
furazolidone. It seems that the difference of clearance time would 
reflect the difference of maximum reached concentration in both 
experiments. However, AOZ residue from both administration routes 
showed same pattern that AOZ reached its maximum levels right after 
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ending treatment. Therefore, it is considered that concentration of AOZ 
reached to maximum level at various dose should be understood to 
decide the optimum withdrawal period.   
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Figure 3.3 Concentration of AOZ in muscle (n = 7) and liver (pooled) of 
Nile tilapia exposed to 2 mg furazolidone/L. 
 
 
 
Table 3.3 Half-life of AOZ in the tissues of Nile tilapia immersed in 
furazolidone 2 mg/L at a water temperature of 28 °C 
 
Equation 
y=C0exp(-kt)* 
 
Tissues 
C0  
(µg/kg) 
k  
(day-1) 
 
Correlation 
coefficient 
(r) 
 
Half-life 
(days) 
 
Muscle 
 
124.97 
 
0.1459 
 
0.9394 
 
5.42 
 
Liver 
 
422.63 
 
0.1278 
 
0.9834 
 
4.75 
*y = concentration after time t, C0 = initial concentration (t=0),  
k = elimination rate. 
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Chapter 4 Relationship between AOZ excretion and 
selected drug-metabolizing enzymes in eel and tilapia 
 
Abstract 
 
Partial liver samples were isolated from eel and tilapia exposed to 
furazolidone. Expression of the following drug-metabolizing  enzymes 
and drug transporter ; phase I (CYP1A & CYP3A), phase II (GST) and 
phase III (ABCG2, MDR1 & SPGP), were quantified by using real-time 
PCR. Among the examined parameters, SPGP which is one of the Phase 
III transporters showed the highest expression level in eel liver at 3 day 
after exposure.  Expressions of CYP1A and GST were increased with the 
passage of time from 1 day to 3 days after exposure. MDR1 gene 
expression was maintained at higher level until 28 days after exposure.  
In tilapia, the dramatic increase of GST gene expression was observed at 
1 day post exposure. Similarly, extreme gene expressions of MDR1 and 
ABCG2 were observed at 1 day and 3hous after exposure, respectively. 
Gene expressions of CYP1A and SPGP were also increased at 3 hours 
after exposure.   These results suggest that the responses of drug 
metabolizing enzymes and drug transporter in Japanese eel are different 
from those of Tilapia and it would be related to the difference of 
concentration of AOZ residues retained in each species.  
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Introduction 
 
Resulting from the administration of furazolidone, AOZ 
(3-amino-2-oxazolidone), which is metabolite of furazoridone, is 
retained in edible portion of livestock and farmed fish for a long time.   
The first potential mutagenesis of AOZ had been reported by 
Hoogenboom, et al., (2002).  Thus, consumption of edible products 
containing AOZ residue even at negligible levels would become a 
problem of public health. Furazolidone is metabolized to the open chain 
cyano-metabolite (3-(4-cyano-2-oxobutylidene amino)-2- oxazolidone),  
by aquatic animals such as eel (Nakabeppu and Tatsumi, 1984), channel 
catfish (Plakas, et al., 1994), trout (Law and Meng, 1996) and grouper 
(Guo, et al., 2003).  It was also revealed that the open chain 
cyano-metabolite of furazoridone is eliminated from tissues as fast as its 
parent chemical. On the other hand,  it has been found that 
protein-bound metabolite (AOZ) elimination is much slower in Nile tilapia 
(Xu, et al., 2006), shrimp (Chu and Lopez, 2005), and Japanese eel and 
tilapia (see in Chapter 3).  The difference on half-life of AOZ elimination 
between Japanese eel and tilapia was observed in previous chapter.  
Well understanding on the differences of furazolidone metabolism and 
AOZ excretion processes between Japanese eel and tilapia should be 
acquired in order to manage the risk of AOZ residues properly in 
aquaculture products.  The objective of present study is to elucidate the 
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key enzymes that relate to elimination of AOZ by examination on gene 
expression of drug-metabolizing enzymes and drug transporter in liver of 
Japanese eel and tilapia.  
 
Materials and Methods 
 
Partial liver sample of eel and tilapia which were exposed to furazolidone, 
as described in the experiment of Chapter 3 were stored in RNAlater 
solution (Ambion) at -20°C until further processing.  Total RNA was 
isolated by using Sepasol RNA I Super (Nacalai Tesque), according to the 
manufacture's protocol. Total RNA (0.1 μg) was subjected to reverse 
transcription by iScript cDNA Synthesis Kit (Bio-Rad).   A tenth of the 
cDNA was used for a real-time PCR reaction. The primers used for 
real-time PCR of eel samples were shown in Table 4.1.  As a reference 
gene, we used β-actin.  Each PCR was performed in a total volume of 20 
μl, made from diluted cDNA template (5 μl), forward and reverse primers 
(4 pmol each), and iQ SYBR Green Supermix (Bio-Rad).  Real-time PCR 
reactions involved an initial denaturation at 95 °C for 3 min followed by 
50 cycles at 95 °C for 15 s, 60 °C 15 s and 72 °C for 15 s, on a 
MiniOpticon (Bio-Rad). Directly after the PCR, the machine performed a 
melting curve analysis by slowly (0.5 °C/s), increasing the temperature 
from 60°C to 95°C.  As quantification of relative expression levels with 
the ΔΔCt method was not possible (i.e., PCR efficiency lower than 100%; 
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Livak and Schmittgen, 2001), we used an efficiency-corrected relative 
expression method (Pfaffl, 2001). 
The primers used for real-time PCR of tilapia samples were shown in 
Table 4.2.  TL32 was used as a reference gene. Real-time PCR reactions 
involved an initial denaturation at 95 °C for 3 min followed by 50 cycles 
at 95 °C for 15 s, 62 °C 15 s and 72 °C for 15 s, on a MiniOpticon 
(Bio-Rad).  Following process was mentioned above as eel samples. 
Table 4.1 Primers for Japanese eel used in real-time PCR 
Primer name Sequence (5’-3’) 
CYP1A-Fwd 
CYP1A-Rev 
CYP3A-Fwd 
CYP3A-Rev 
µGST-Fwd 
µGST-Rev 
ABCG2-Fwd 
ABCG2-Rev 
MDR1-Fwd (ABCB4-Fwd) 
MDR1-Rev(ABCB4-Rev) 
SPGP-Fwd 
SPGP-Rev 
β-actin-Fwd 
β-actin-Rev 
TGAGGACAGGAAACTGGATGAG 
AACAGCCCATGACAAAGCAG 
AAGACTCGTTCAGTGCCATATCC 
GCCACCAACCCTGAAACAA 
GGCTTCGTCATGCTCTGCTAC 
CTGCAACCACTTCCTGTCTCC 
TCTCCGTCTACTTCCTGTCCAA 
CGTGGCCTTCAGTCCTATCA 
AAGGTCTGCCCCTTCTTCAC 
CGGACAAGTTCGACGGAAAC 
TGATCCAGTTGCCCAGAGAG 
GGAGAAAGCATAGCCCTGAAGA 
CCTGTTCCAGCCTTCCTTCC 
ACGGTGTTGGCGTACAGGTC 
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Table 4.2 Primers for tilapia used in real-time PCR   
Primer name Sequence (5’-3’) 
CYP1A-Fwd 
CYP1A-Rev 
CYP3A-Fwd 
CYP3A-Rev 
αGST-Fwd 
αGST-Rev 
ABCG2-Fwd 
ABCG2-Rev 
MDR1-Fwd 
MDR1-Rev 
SPGP-Fwd 
SPGP-Rev 
TL32-Fwd 
TL32-Rev 
AACAAGGTAGAGGGAGAGAAGGTG 
TGAGAATAGCCAAGAAGAGGAAGAG 
AAAAGCTGCAGGAGGAGGTG 
GTGAAGCAATGGGGAACAATC 
ATGTTGGCAAAGCCAGGAAG 
TTCCAGGGTGTTTTGGTGTG 
ATGGATGTGGCGGTGTAGG 
CATCCCCGCTATCGTCTTC 
GTTTCCGTTTTGGTGCTTGG 
CGTAGTTTGGAGCGAAGGAGTTG 
GGGCCTCATACATCTACACAAAGG 
TCGCCAAACAGGACAAGGAG 
GACCAAGTTCATGCTGCCAAC 
TGCCCTCTCCACAATCAGC 
 
Results and Discussion 
 
Drug-metabolizing enzymes (DMEs) play central roles in the 
metabolism, elimination and detoxification of xenobiotics and drugs 
absorbed into the organisms.  Most of the tissues and organs in animal 
body are well equipped with diverse DMEs including phase I and phase II 
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metabolizing enzymes and phase III transporters, which are present in 
abundance at the basal unstimulated level, are inducible at elevated level 
after exposure to xenobiotics (Xu, et al. 2005; Guengerich, 2003; Lampe, 
1999; Zimniak, et al., 1999).  Determination of the concentrations of 
AOZ in the liver and gene expression of drug metabolizing enzymes was 
attempted to show a casual relationship between exposure and response 
in different species. Japanese eel and tilapia were immersed to the same 
dose of furazolidone (2 mg/L). However, the residual AOZ in liver tissues 
reached to the peak at 1 day in Japanese eel and immediately after 
stopping exposure in tilapia, respectively (Fig 4.1).   
Cytochrome P450 1A (CYP1A) and cytochrome P450 3A (CYP3A) 
expression levels were the representative of phase I enzymes.  CYP1A is 
well known as the key phase I detoxification enzyme that play significant 
roles in the biosynthesis or oxidative metabolism of many endogenous 
and exogenous compounds (Coon, et al., 1992; Juchau, 1990).  The 
induction of CYP1A in various fish species has been widely used as a 
biomarker of contamination in the aquatic environment (Aubry, et al., 
2008; Franco, et al., 2008; Mariottini, et al., 2008; Salamanca, et al., 
2008; Sturve, et al., 2008; Wang, et al., 2006; Mahata, et al., 2003; Bard, 
et al., 2002; Gadagbui and Goksøyr, 1996; Gadugbui, et al., 1996).  
CYP3A is involved in metabolic clearance of numerous chemical 
compounds.  Most studies of CYP3A have been performed in mammals, 
whereas little is known in fish (grass carp; Li, et al., 2008; zebra fish; 
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Tseng, et al., 2005, killifish; Hegelund and Celander, 2003). In fish, 
CYP3A gene is expressed in the digestive tracts and respiratory organ 
and it is suggested that CYP3A is important for the first-pass effect of 
xenobiotics, similar to mammals.  The highest expression of CYP1A 
(7.4-fold) was observed in tilapia liver as well as CYP3A (2.3-fold) 
promptly after stopping immersion.  This highest expression level of 
CYP1A in tilapia liver appeared to be potent responder of furazolidone 
metabolism since it sympathized with the peak of maximal AOZ residue 
(Fig 4.2).  The highest expression of CYP1A (3.3-fold) occurred in eel 
liver at 3 days after exposure, however, the obvious change of CYP3A 
expression was not observed during the experiment.  The highest 
expression level of CYP1A appeared at close time when the highest level 
of AOZ residue in eel liver was detected.  However, since increase of 
CYP1A gene expression was only about 3 times higher than the basal 
level. These results suggest that one of major contributor to the 
response for furazoridone metabolism is CYP1A, while the response is 
feeble in comparison with tilapia.  These results were contrary with 
those incidents in rat liver (Rahden-Staron, et al., 2001).  As the 
cytochrome P450 consists of many isoenzymes, other enzymes may be 
related to furazolidone metabolism in Japanese eel 
Among phase II metabolizing or conjugating enzymes, Glutathione 
S-transferase (GST) has been widely studied. It consists of many 
superfamily or isoenzymes.   The responses of this enzyme to various 
Relationship between AOZ excretion and selected 
drug-metabolizing enzymes in eel and tilapia 
 
 85
chemicals have been evaluated in numerous fishes (Salamanca, et al., 
2008; Franco, et al., 2008; Wang, et al., 2006; Liao, et al., 2006; 
Gadagbui and Goksøyr, 1996; Gadagbui, et al., 1996).  In the present 
study, gene expression of GST of tilapia exposed to furazolidone was 
extremely raised (214-fold) at 1 day after exposure, while that of eel 
reached to the maximum level (4.5-fold) at 3 days after exposure (Fig 
4.3).  The detoxification reaction induced by phase I enzyme may be 
incomplete, since AOZ is a non-polar part of furazolidone which is hard to 
eliminate rapidly from body. In general, the hydrophilicity of chemical 
substances conjugated with phase II DMEs generally increases, and 
thereby excretion of the conjugated chamicals into the bile and/or the 
urine is enhanced, consequently phase II DMEs show a detoxification 
effect (Xu, et al. 2005, Moscow and Dixon, 1993). GST catalyze the 
formation of glutathione conjugate, which is hydrophilic substance, with 
various chemicals. The fact that gene expression of GST in tilapia liver 
was much higher than that of Japanese eel indicates that GST would play 
an important role on rapid elimination of AOZ in tilapia.  
Phase III transporters are well studied in human. Those are 
expressed in many tissues where they provide a formidable barrier 
against drug penetration such as the liver, intestine, kidney, and brain, 
and play crucial roles in drug absorption, distribution and excretion(Xu, 
et al. 2005; Ejendal and Hrycyna, 2002; Dean, et al. 2001; Zimniak, et al. 
1999;). There also are some reports on Phase III transporters in fish 
Relationship between AOZ excretion and selected 
drug-metabolizing enzymes in eel and tilapia 
 
 86
(Žaja, et al. 2008; Annilo, et al. 2006; Bard, et al. 2002; Albertus and 
Laine, 2001).  It is suggested that multidrug resistance gene 
(MDR1/ABCB1), sister of P-gp gene (SPGP) and a member of 
ATP-binding cassette of transporters (ABCG2) relate to drug excretion. 
Therefore, these drug transporters were examined in this present study.  
Overexpression of these transporters would become a problem for 
successful treatment (Ejendal and Hrycyna, 2002), however, this 
incident would be benefit for successful excretion of unwanted harmful 
chemicals in farmed fish.  The highest expression of SPGP (9-fold) was 
observed   at 3 days after exposure.  Gene expression of MDR1 was 
increased at 1 day after exposure (2.8-fold) and maintained until 28 days, 
whereas ABCG2 remained unchanged in Japanese eel liver (Fig 4.4). The 
expression of MDR1 in tilapia liver rose up immediately (7-fold) and 
reached the maximum level (80-fold) at 1 day after exposure. After that, 
it returned to basal level. The expressions of SPGP (5-fold) and ABCG2 
(23-fold) were increased obviously at 3h after exposure and decreased 
rapidly to basal level. 
In present study, the difference of gene expression of drug 
metabolizing enzymes was observed between Japanese eel and tilapia.  
The degree of the change on same gene expression was also different 
between two species.  It is considered that the difference on gene 
expression of drug metabolizing enzymes examined in this study are 
related to the difference on the concentration of AOZ residues detected in 
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eel and tilapia liver tissues.  Gene expressions of GST and MDR1 were 
elevated in both eel and tilapia livers.  This result suggests that GST and 
MDR1 would play an important role on furazolidone metabolism and 
excretion in both species.  On the other hand, increases of ABCG2 and 
CYP1A gene expression are only observed in tilapia. Since AOZ was more 
rapidly eliminated from tilapia, these enzymes may be concerned in the 
excretion for the drug.   
In conclusion, the most potent drug metabolizing enzymes and drug 
transporters against furazolidone are SPGP, GST and MDR1 in eel liver, 
and are GST, MDR1, ABCG2 and CYP1A in tilapia liver, respectively (Table 
4.3).  
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Table 4.3 Summary of drug metabolizing enzymes (DMEs) and drug 
transporter gene expression related to furazolidone metabolism and 
elimination 
 
DMEs Japanese eel Tilapia 
Phase I Other CYP isoenzymes? CYP1A 
Phase II GST GST 
Phase III SPGP, MDR1 MDR1, ABCG2, SPGP 
 
 
 
 
Figure 4.1 AOZ residues detected in liver from tilapia (●); and eel (■) 
after exposed to furazolidone at dose of 2 mg/L for 3 hours. 
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Figure 4.2 CYP1A and CYP3A mRNA expression in liver of Japanese eel 
and tilapia exposed to furazolidone at dose of 2 mg/L for 3 hours. 
 
 
Figure 4.3 GST mRNA expression in liver of Japanese eel and tilapia 
exposed to furazolidone at dose of 2 mg/L for 3 hours. 
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Figure 4.4 SPGP, MDR1 and ABCG2 mRNA expression in liver of Japanese 
eel and tilapia exposed to furazolidone at dose of 2 mg/L for 3 hours. 
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Chapter 5 Enhancement of AOZ excretion by Chinese 
parsley supplementation from Japanese eel 
 
Abstract 
 
To evaluate the effectiveness of Chinese parsley regarding 
enhancement of AOZ excretion from Japanese eel, fish were fed a diet 
containing 2 g parsley/kg BW after exposure to 2 and 10 mg 
furazolidone/L for 3 hr.  AOZ residues in muscle and liver were 
monitored   from 7th days after exposure.  The obviously evidence that 
parsley supplemented-diet improve AOZ excretion from eel tissues was 
not obtained.  These evidences were confirmed by the gene expression 
of drug metabolizing enzyme after feeding of parsley supplemental diet 
or intraperitoneal injection of myristicin. 
 
Introduction 
 
A potential to cause unexpected chemical residues in farmed fish 
exist, even if the farmed fish producers do not use any of those 
chemicals.  In fact, leucomalachite green residues were found in farmed 
amberjack that were produced without using malachite green.  This is 
the serious problem for chemical risk management in Japan under the 
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enforcement of the “Positive List System for Agricultural Chemical 
Residues in Foods” since May 2006 (Ministry of Health, Labor and 
Welfare, 2006). In order to prevent chemical residues, such as 
veterinary drugs, pesticides or other harmful chemicals, in aquaculture 
products, proper management complying with GAP (Good Aquaculture 
Practice) should be implemented. Even if the fish farmers implement 
proper management complying with GAP, it is difficult to prevent 
chemical residues caused by the contamination of aquaculture feed. 
The addition of feed additives having the effect of enhancement of the 
elimination of chemical may be a countermeasure that can reduce the 
risk of unexpected residues in aquaculture system.  
In this study, the potential of Chinese parsley to enhance AOZ 
elimination was investigated. In China, Chinese parsley (Coriandrum 
sativum) is eaten as a common vegetable and also has long been used 
as a traditional herbal medicine for the treatment of stomach or 
intestinal ailment.  The preventive effect of Chinese parsley against 
accumulation of heavy metal (Lead and Aluminum) in IRC mice was 
studied by Aga, et al. (2002 and 2001).  The effect of Chinese parsley 
on inhibiting the accumulation of toxic Cadmium (Cd) in cultured 
rainbow trout, Oncorhynchus mykiss has been reported by Ren, et al. 
(2006). Our previous examination found that supplementary of 2 g 
parsley/kg in fish feed had more capacity to eliminate oxytetracycline 
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residue from edible tissue of Japanese flounder (Krongpong, et al., 
2007).  Therefore, the present study aimed to assess the potency of 
Chinese parsley supplementation in diet to enhance AOZ residue 
excretion from Japanese eel. 
 
Materials and methods 
 
1. Chemicals 
All chemicals used in this experiment were mentioned in Chapter 
3. 
2. Experimental protocol and sampling 
Japanese eel from Chapter 3 were also used in this study.  Fish 
were immersed to furazolidone at concentration of 2 and 10 mg/L in 
static water for 3 h after that circulated with well water at flow rate of 
1.2 L/min.   Fish were fed a commercial feed at the rate of 1% body 
weight per day as a control group. Another group of fish was fed with 
commercial diet mixed with 2 g parsley/kg BW.  Preparation of parsley 
was described by Ren, et al. (2006).  Fish were sampled at each of the 
following time points after the 7 day.  At each scheduled sampling time, 
muscle and liver samples were taken as described in Chapter 3 for 
analysis of AOZ concentration by ELISA.  Samples were stored at -20 C 
until analysis.  The expression of selected drug-metabolizing enzymes 
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(CYP1A, MDR1 and SPGP) was analyzed by real-time PCR as mentioned 
in Chapter 4. In order to confirm the effectiveness of active component 
of parsley-myristicin, fish were injected myristicin from parsley leaf 
(SIGMA, Germany) dissolved in soybean oil at doses of 250, 500 and 
1,000 µmol/kg BW intraperitoneally.  Control injection was performed 
by injection of soybean oil.  The expression of drug metabolizing 
enzymes had been analyzed as in Chapter 4. 
 
Results and Discussion 
 
Results of the concentration of AOZ in Japanese eel liver and 
muscle tissues in fish fed experimental diet are shown in Table 5.1 and 
5.2, respectively.  The patterns of AOZ excretion from both tissues in 
the fish fed diet containing 2 g parsley/kg were similar to the fish fed 
control diet.  AOZ concentrations in muscle tissue from fish fed diet 
supplemented with 2 g of parsley/kg significantly lower   (p<0.05) than 
that of control at 42 days after 10 mg furazolidone/L exposure.  
However, there is no significant difference between parsley 
supplemented-group and control at other sampling points in both 
concentration of furazolidone immersion. Similarly,   no significant 
difference (p>0.05) between the experimental groups on excretion of 
AOZ residue from the liver was observed.  These results show that 
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supplementation of Chinese parsley have no effects of enhance AOZ 
elimination from tissues in Japanese eel. 
Chinese parsley has been used not only as a spice but also as a 
traditional natural medicine for the treatment of diabetes in Europe 
(Gray and Flatt, 1999) and stomach or intestinal ailments (Ren, et al., 
2006).  Ren et al. (2006) examined the inhibitory action of Chinese 
parsley on cadmium accumulation in cultured rainbow trout 
(Oncorhychus mykiss). According to their results, the inhibition of Cd 
accumulation was observed in 2 g parsley/kg mixed to the feed, and 
the additional of Chinese parsley had no effects on any physical 
measurement and the growth rate of experimental fish.  Our previous 
examination found that supplementary of 2 g parsley/kg in fish feed 
had more capacity to eliminate oxytetracycline residue from edible 
tissue of Japanese flounder (Krongpong, et al., 2007). Therefore, it was 
considered that 2 g parsley/kg would be a practical dose for Japanese 
eel. According to all above reports the additional of feed additives 
would be considered as a chance to avoid undesirable substances left 
over in aquaculture products and manage the risk of chemical residues 
in aquaculture system which would be alleviated public health concerns. 
However, it was revealed that the  supplementation of Chinese parsley 
at the dose of 2 g parsley/kg have no effects of enhance AOZ 
elimination from tissues in Japanese eel. Based on our results, 
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supplementation of 2 g parsley/kg BW in fish feed had no capacity to 
eliminate AOZ residue from edible tissue of Japanese eel.  Platel and 
Srinivasan (2000) reported the influence of dietary coriander on the 
biliary solids of rats.  They pronounced a higher rate of secretion of bile 
acids was caused by coriander supplementation. As OTC is excreted 
into bile, it is considered that the effect of Chinese parsley on OTC 
excretion would be brought by the increase of bile acid induced by the 
supplementation of Chinese parsley.  Although it has not been revealed 
that AOZ is excreted into bile or not, the difference of AOZ excretion 
route may be a reason why Chinese parsley did not show the effect of 
enhancing AOZ excretion in Japanese eel.    As some selected drug 
metabolizing enzymes genes (GST, SPGP and MDR1) were upregulated 
by the exposure to furazolidone, these enzymes would be a major 
contributor involved in detoxication of furazolidone and excretion of 
AOZ in Japanese eel (see Chapter 4).  There was no significant 
difference of CYP1A, SPGP and MDR1 expression levels between control 
and parsley supplemental groups (Fig 5.1). The fact that 
supplementation of Chinese parsley did not show the effects of 
upregulation of drug metabolizing enzymes may also be connected with 
the reason why Chinese parsley did not show the effect of enhancing 
AOZ excretion. 
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It has been reported that myristicin is an active constituent of 
parsley leaf which has been shown to induce the activity of drug 
metabolism enzymes such as cytochrome P450 (Jeong and Yun, 1995) 
and glutathione S-transferase (Ahmad, et al., 1997) in rat liver.  The 
expression levels of CYP1A, SPGP and MDR1 in fish injected with 1,000 
µmol/kg BW of myristicin were elevated obviously at 24 h after 
injection (Fig 5.2). However, expression of these enzymes in fish 
injected with 250 and 500 µmol/kg BW of myristicin were similar to 
those of control. These results suggest that the amount of Chinese 
parsley equal to 1,000 µmol/kg BW of myristicin is required if the active 
component of Chinese parsley is myristicin. According to the 
composition of myristicin in Chinese parsley reported by Arak et al. 
(2007) the amount of myristicin contained in 2g of Chinese parsley is 
less than 500 µmol.  Therefore, the dose of Chinese parsley used in this 
experiment may be inefficient to enhance the excretion of AOZ from 
Japanese eel.  If the quantity of Chinese parsley supplemented in diet 
is increased, it is feared that feed intake of fish is reduced because of 
its smell.  Other materials that have the ability to enhance the 
excretion of AOZ should be screened by the monitoring of gene 
expression of drug metabolizing enzymes. 
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Table 5.1 AOZ concentrations in muscle (µg/kg) from Japanese eel 
exposed to 2 and 10 mg furazolidone/L and fed with or without 2 g 
parsley/kg BW diet 
2 mg/L 10 mg/L Sampling 
time (day) control experimental control experimental 
 
7 
14 
28 
42 
56 
73 
84 
101 
118 
132 
146 
160 
 
66.15±9.75 
35.74±6.08 
16.55±1.88 
8.83±2.17 
3.94±0.32 
2.92±0.72 
2.96±0.66 
2.55±0.744 
1.87±0.45 
1.15±0.31 
0.96±0.11 
0.56±0.16 
 
71.37±4.31 
38.85±5.18 
17.82±3.83 
7.91±1.93 
4.77±0.60 
3.66±1.28 
2.57±0.35 
3.15±0.51 
2.44±0.47 
1.85±0.40 
1.22±0.10 
0.93±0.19 
 
238.69±28.20 
113.81±21.63 
56.77±7.30 
37.10±4.02 
15.87±5.33 
11.21±1.94 
8.57±1.83 
8.34±1.37 
7.81±1.77 
3.45±1.17 
4.74±1.55 
2.71±0.67 
 
213.59±35.29 
122.34±23.59 
54.07±7.56 
28.25±6.52* 
14.19±1.34 
11.80±4.56 
8.48±1.63 
6.33±2.98 
7.13±3.40 
4.27±2.10 
4.69±1.12 
2.75±1.16 
Value present means ± S.D. from 5 fish, * p<0.05. 
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Table 5.2 AOZ concentrations in liver (µg/kg) from Japanese eel 
exposed  to 2 and 10 mg furazolidone/L and fed with or without 2 g 
parsley/kg BW diet 
2 mg/L 10 mg/L Sampling 
time (day) control experimental control experimental 
 
7 
14 
28 
42 
56 
73 
84 
101 
118 
132 
146 
160 
 
196.924 
127.944 
24.914 
16.950 
7.730 
7.306 
7.624 
6.478 
2.823 
1.489 
1.188 
1.022 
 
200.426 
121.305 
14.926 
14.520 
8.090 
6.353 
5.297 
4.519 
2.917 
1.971 
1.243 
1.032 
 
605.582 
380.816 
117.320 
78.368 
34.350 
17.191 
20.286 
13.602 
8.816 
7.040 
6.137 
2.740 
 
571.058 
266.208 
85.150 
65.194 
35.970 
19.983 
17.542 
10.064 
8.100 
8.148 
4.353 
3.219 
Remark; samples were pooled form 5 fish. 
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Figure 5.1 CYP1A, SPGP and MDR1 mRNA expression in eel liver after 
   exposed to furazolidone and fed with or without Chinese parley.  
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Figure 5.2 CYP1A, SPGP and MDR1 mRNA expression in eel liver after 
    injected with various doses of myristicin. 
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Chapter 6 General conclusion 
In recent years, the presence of chemical residues in food has 
become an issue of intense international concerns.  Consumers all over 
the world have been expressing their sincere desire for a drug-free 
food supply.     Consumers require the assurance on the chemical 
safety of the product, especially aquaculture products because farmed 
fish are in various risks associated with chemical contamination at any 
levels.  One of the most serious problems in the safety of farmed fish 
is furazolidone. Nitrofurans had been previously used in livestock 
industry and aquaculture, however, the use of nitrofurans has been 
banned in most countries recently because of its potential 
carcinogenicity and mutagenicity.  Despite, furazolidone was prohibited 
to use for food producing animals including aquatic animal; 
furazolidone residue is still detectable by means of metabolite form 
(AOZ).  The present study was focused on the creation of sufficient 
data that lead to ensure safety of farmed fish products and establish 
proper risk management.  The conclusion derived from the series of 
experiments provided some scientific knowledge on the proper risk 
management of furazolidone residue in farmed Japanese eel. 
 
In Japan, the Food Sanitation Law requires that nitrofuran residues 
in food should be less than the detection limits of the analytical 
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methods approved by the Ministry of Health Labor and Welfare. In the 
case of AOZ, the detection limit for the LC-MS/MS method has been 
set at 1 µg/kg. However, measurement of AOZ by LC-MS/MS has some 
problems that cause insufficient frequency of monitoring of AOZ 
residue. There is now an urgent need for rapid, suitable, high capacity 
and less cost screening methods for tissue bound residues of 
furazolidone (AOZ) in farmed fish, especially in Japanese eel produced 
in Japan and imported from china or Taiwan.  In chapter 2, verification 
of ELISA-based method for detecting AOZ in Japanese eel tissues had 
been done. The procedures of AOZ extraction from eel tissues was 
slightly modified, consequently ELISA method became suitable for 
regulatory purposes and for studying the fate of AOZ residues in eel 
treated with furazolidone. This ELISA is capable of detecting AOZ at 
1.0 µg/kg in an eel sample with excellent accuracy and precision. 
ELISA-based kit will provide a chance to increase the frequency of 
monitoring, and then lead to reduce the risk of AOZ residue.   
In chapter 3, the clearance of AOZ in Japanese eel was investigated. 
Consequently, it was revealed that (1) half-life of AOZ in muscle from 
Japanese eel exposed to furazolidone is about 25 days regardless of 
the dose; (2) water temperature is an important factor affecting AOZ 
residues in Japanese eel tissues, knowing the half-lives of AOZ in 
animal tissues will make it easier to estimate the elimination time.  On 
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the basis of the elimination time, a period can be fixed during which 
harvesting the animals should be prohibited. Although the data were 
not shown here, surveillance of AOZ residue in farmed eel produced in 
Japan in cooperation with Japan Farmed Eel Association has been 
carried out.  Among 180 samples examined by ELISA kit, a positive 
sample was found. The fish farmer prohibited harvest immediately; as 
a result, distribution of the violated products into the market was 
prevented. This is a successful case of self-imposed monitoring of AOZ 
by ELISA method.  
 
Expression of the following drug-metabolizing  enzymes and drug 
transporter ; phase I (CYP1A & CYP3A), phase II (GST) and phase III 
(ABCG2, MDR1 & SPGP), were quantified by using real-time PCR 
(Chapter 4).  The differences on gene expression of drug metabolizing 
enzymes and drug transporters were observed between Japanese eel 
and tilapia.  The degree of the change on same gene expression was 
also different between two species.   It is suggested that these 
differences on activities of drug metabolizing enzymes and drug 
transporters are related with the difference of AOZ elimination among 
the fish species. Further investigations on gene expression of drug-
metabolizing enzymes and drug transporter such as CYP1A, GST, 
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ABCG2, MDR1 and SPGP in various fish species will provide useful 
information for prediction of AOZ residue risk in other species.  
 
The potency of Chinese parsley supplementation in diet on 
enhancement of AOZ excretion from Japanese eel was examined as a 
new countermeasure of AOZ residue control (Chapter 5).  However, 
Chinese parsley supplemented diet showed inefficient to activate the 
elimination of AOZ residues from farmed eel.  This control measures by 
feed additives would be more important in future aquaculture activities 
since it is difficult to prevent chemical residues caused by the 
contamination through aquaculture feed or juvenile stages.  Additional 
studies should be tried to find out new materials which have the 
potential to enhance chemicals elimination.  
 
Last but not least, all data obtained from this research would help 
the eel farmers to promote safe eel production.  
